AP NEWS
Press release content from Business Wire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

Breath Biopsies 2019: A Revolutionary Approach for Noninvasive Diagnosis - ResearchAndMarkets.com

November 22, 2019

DUBLIN--(BUSINESS WIRE)--Nov 22, 2019--

The “Breath Biopsies: A Revolutionary Approach for Noninvasive Diagnosis” report has been added to ResearchAndMarkets.com’s offering.

Report Includes:

Summary

In the future, a variety of conditions may be diagnosed with a simple breath test. Researchers are looking beyond blood tests and solid/liquid biopsies to find other sources of information to diagnose disease. Every time an individual breathes, thousands of volatile organic compounds (VOCs) and volatile fatty acids (VFAs), the breakdown products of lipids and proteins,1 are released into the breath. These novel biomarkers are by-products of metabolism, and can provide a snapshot of an individual’s health.

Key Topics Covered:

Chapter 1 Monitoring Volatile Organic Compounds

Chapter 2 Value Proposition of Breath Testing

Chapter 3 Applications in Diagnostics

Chapter 4 Companies and Technologies for Which to Watch Out

Chapter 5 References

For more information about this report visit https://www.researchandmarkets.com/r/vhlmxq

View source version on businesswire.com:https://www.businesswire.com/news/home/20191122005194/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

KEYWORD:

INDUSTRY KEYWORD: HEALTH PHARMACEUTICAL

SOURCE: Research and Markets

Copyright Business Wire 2019.

PUB: 11/22/2019 06:09 AM/DISC: 11/22/2019 06:09 AM

http://www.businesswire.com/news/home/20191122005194/en